Role of Targeted Therapy in Dilated Cardiomyopathy: The Challenging Road Toward a Personalized Approach

Job A. J. Verdonschot*, Mark R. Hazebroek, James S. Ware, Sanjay K. Prasad, Stephane R. B. Heymans

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

Original languageEnglish
Article number012514
Number of pages18
JournalJournal of the American Heart Association
Volume8
Issue number11
DOIs
Publication statusPublished - 4 Jun 2019

Keywords

  • dilated cardiomyopathy
  • personalized
  • phenotyping
  • therapy
  • CHRONIC HEART-FAILURE
  • CLINICAL-PRACTICE GUIDELINE
  • MYOCARDIAL FIBROSIS
  • ATRIAL-FIBRILLATION
  • PERIPARTUM CARDIOMYOPATHY
  • IMMUNOSUPPRESSIVE THERAPY
  • INCREASE CONTRACTILITY
  • DIASTOLIC DYSFUNCTION
  • POSITION STATEMENT
  • OMECAMTIV MECARBIL

Cite this